High affinity binding of epibatidine to serotonin type 3 receptors

Journal of Biological Chemistry

Volumn 283, Issue 15, 2008, Pages 9659-9665

  Drisdel, Renaldo C ^a   Sharp, Douglas ^b   Henderson, Tricia ^b   Hales, Tim G ^b   Green, William N ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING ENERGY; BIOCHEMISTRY; CELL CULTURE; CELL MEMBRANES; COMPETITION; LIGANDS; PYRIDINE;

COMPETITIVE INHIBITORS; EPIBATIDINE; HIGH AFFINITIES; HIGH AFFINITY BINDINGS; NEUROBLASTOMA CELL LINES; NICOTINIC ACETYLCHOLINE RECEPTORS (NACHRS); PERIPHERAL NERVOUS SYSTEMS; RAT BRAINS;

BINDING SITES;

1 (3 CHLOROPHENYL)BIGUANIDE; BEMESETRON; EPIBATIDINE; IODINE 125; MECAMYLAMINE; NICOTINE; SEROTONIN; SEROTONIN 3 RECEPTOR; FUSED HETEROCYCLIC RINGS; NICOTINIC AGENT; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR BLOCKING AGENT; PYRIDINE DERIVATIVE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING SITE; BRAIN; BRAIN MEMBRANE; DRUG BINDING; EMBRYO; HUMAN; HUMAN CELL; MOUSE; NEUROBLASTOMA CELL; NONHUMAN; PRIORITY JOURNAL; ANIMAL; BRAIN LEVEL; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; METABOLISM; PROTEIN BINDING; RAT; TUMOR CELL LINE;

RATTUS;

ANIMALS; BICYCLO COMPOUNDS, HETEROCYCLIC; BRAIN; BRAIN CHEMISTRY; CELL LINE, TUMOR; HUMANS; MECAMYLAMINE; MICE; NICOTINE; NICOTINIC AGONISTS; NICOTINIC ANTAGONISTS; PROTEIN BINDING; PYRIDINES; RATS; RECEPTORS, NICOTINIC; RECEPTORS, SEROTONIN, 5-HT3;

EID: 44349193484     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M703672200     Document Type: Article

References (74)

1. Spande, T. F., Garraffo, H. M., Edwards, M. W., Yeh, H. J. C., Panne, L., and Daly, J. W. (1992) J. Am. Chem. Soc. 114, 3475-3478
2. Badio, B., and Daly, J. W. (1994) Mol. Pharmacol. 45, 563-569
3. Bonehaus, D. W., Bley, K. R., Broka, C. A., Fontana, D. J., Leung, E., Lewis, R., and Wong, S. A. (1995) J. Pharmacol. Exp. Ther. 272, 1199-1203
4. Houghtling, R. A., Davila-Garcia, M. I., and Kellar, K. J. (1995) Mol. Pharmacol. 48, 280-287
5. Ulrich, Y. M., Hargreaves, K. M., and Flores, C. M. (1997) Neuropharmacology 36, 1119-1125
6. Gerzanich, V., Peng, X., Wang, F., Wells, G., Anand, R., Fletcher, S., and Lindstrom, J. (1995) Mol. Pharmacol. 48, 774-782
7. Dobelis, P., Hutton, S., Lu, Y., and Collins, A. C. (2003) J. Pharmacol. Exp. Ther. 306, 1159-1166
8. Boyce, S., Webb, J. K., Shepheard, S. L., Russell, M .G. N., Hill, R. G., and Rupniak, N. M. J. (2000) Pain 85, 443-450
9. Fisher, M., Huangfu, D., Shen, T. Y., and Guyenet, P. G. (1994) J. Pharmacol. Exp. Ther. 270, 702-707
10. Radek, R. J., Curzon, P., and Decker, M. W. (2004) Brain Res. Bul. 64, 323-330
11. Damaj, M. I., Creasy, K. R., Grove, A. D., Rosecrans, J. A., and Martin, B. R. (1994) Brain Res. 664, 34-40
12. Rashid, M. H., Furue, H., Yoshimura, M., and Ueda, H. (2006) Pain 125, 125-135
13. Young, J. M., Shytle, R. D., Sandberg, P. R., and George, T. P. (2001) Clin. Ther. 23, 532-565
14. Connolly, C. N., and Wafford, K. A. (2004) Biochem. Soc. Trans. 32, 529-534
15. Ortells, M. O., and Lunt, G. G. (1995) Trends Neurosci. 18, 121-127
16. Maricq, A. V., Peterson, A. S., Brake, A. J., Myers, R. M., and Julius, D. (1991) Science 254, 432-437
17. Werner, P., Kawashima, E., Reid, J., Hussy, N., Lundstrom, K., Buell, G., Humbert, Y., and Jones, K. A. (1994) Mol. Brain Res. 26, 233-241
18. Bucaffusco, J. J. (1996) Pharmacol. Rev. 48, 179-211
19. Costall, B., and Naylor, R. J. (2004) Curr. Drug Targets CNS Neurol. Disord. 3, 27-37
20. Iwamoto, E. T., and Marion, L. (1993) J. Pharmacol. Exp. Ther. 265, 777-789
21. Saxena, P. R., and Villalon, C. M. (1990) J. Cardiovasc. Pharmacol. 15, Suppl. 7, 17-34
22. Ferezou, I., Cauli, B., Hill, E. L., Rossier, J., Hamel, E., and Lambolez, B. (2002) J. Neurosci. 22, 7389-7397
23. Decker, M. W., Curzon, P., Holladay, M. W., Nikkel, A. L., Bitner, R. S., Bannon, A. W., Donnelly-Roberts, D. L., Puttfarcken, P. S., Kuntzweiler, T. A., Briggs, C. A., Williams, M., and Arneric, S. P. (1999) J. Physiol. 92, 221-224
24. Cordero-Erausquin, M., Marubio, L. M., Klink, R., and Changeux, J. (2000) Trends Pharmacol. Sci. 21, 211-217
25. Farber, L., Haus, U., Spath, M., and Drechsler, S. (2004) Scand. J. Rheumatol. 33, 2-8
26. Bitner, R. S., Nikkel, A. L., Curzon, P., Arneric, S. P., Bannon, A. W., and Decker, M. W. (1998) J. Neurosci. 18, 5426-5432
27. Cucchiaro, G., Chaijale, N., and Commons, G. (2005) J. Pharmacol. Exp. Ther. 313, 389-394
28. Gilbert, S. D., Clark, T. M., and Flores, C. M. (2001) Pain 89, 159-165
29. Khan, I. M., Buerkle, H., Taylor, P., and Yaksh, T. L. (1998) Neuropharmacology 37, 1515-1525
30. Lawand, N. B., Lu, Y., and Westlund, K. N. (1999) Pain 80, 291-299
31. Zhang, L., Oz, M., and Weight, F. F. (1995) Neuroreport 8, 1464-1468
32. Zeitz, K. P., Guy, N., Malmberg, A. B., Dirajlal, S., Martin, W. J., Sun, L., Bonehaus, D. W., Stucky, C. L., Julius, D., and Basbaum, A. I. (2002) J. Neurosci. 22, 1010-1019
33. Moore, K. A., Oh, E. J., and Weinreich, D. (2002) J. Appl. Physiol. 92, 2529-2534
34. Ali, Z., Wu, G., Kozlov, A., and Barasi, S. (1996) Neurosci. Lett. 208, 203-207
35. Alhaider, A. A., Lei, S. Z., and Wilcox, G. L. (1991) J. Neurosci. 11, 1881-1888
36. Holliday, M. W., Wasicak, J. T., Lin, N., He, Y., Ryther, K. B., Bannon, A. W., Buckley, M. J., Kim, D. J. B., Decker, M. W., Anderson, D. J., Cambell, J. E., Kuntzweiler, T. A., Donnelly-Roberts, D. L., Piattoni-Kaplan, M., Briggs, C. A., Williams, M., and Arneric, S. P. (1998) J. Med. Chem. 41, 407-412
37. Hoffman, W. E., Schmid, P. G., and Phillips, M. I. (1978) J. Pharmacol. Exp. Ther. 206, 644-651
38. Tseng, C.-J., Appalsamy, M., Robertson, D., and Mosqueda-Garcia, R. (1993) J. Pharmacol. Exp. Ther. 265, 1511-1518
39. Alkadhi, K. A., Otoom, S. A., Tanner, F. L., Sockwell, D., and Hogan, Y. H. (2001) 226, 1024-1030
40. Ferreira, H. S., Silva, E. C., Cointeiro, C., Oliveira, E., Faustino, T. N., and Fregoneze, J. B. (2004) Brain Res. 1028, 48-58
41. Gerges, N. Z., Aleisa, A. M., Alhaider, A. A., and Alkadhi, K. A. (2002) Neuropharmacology 43, 1070-1076
42. Stitzel, J. A., Jimenez, M., Marks, M. J., Tritto, T., and Collins, A. C. (2000) J. Pharmacol. Exp. Ther. 293, 67-74
43. Dani, J. A., and Bertrand, D. (2007) Annu. Rev. Pharmacol. Toxicol. 47, 699-729
44. Butt, C. M., King, N. M., Stitzel, J. A., and Collins, A. C. (2004) J. Pharmacol. Exp. Ther. 308, 591-599
45. Wada, Y., Shiraishi, J., Nakamura, M., and Koshino, Y. (1997) Brain Res. 759, 313-316
46. Grant, K. A., Hellevuo, K., and Tabakoff, B. (1994) Alcohol. Clin. Exp. Res. 18, 410-414
47. Anuradha, K., Hota, D., and Pandhi, P. (2004) Indian J. Exp. Biol. 42, 368-372
48. Sepulveda, M. I., Baker, J., and Lummis, S. C. (1994) Neuropharmacology 33, 493-499
49. Lummis, S. C., Kilpatrick, G. J., and Martin, I. L. (1990) Eur. J. Pharmacol. 189, 22-27
50. Hope, A. G., Belelli, D., Mair, I. D., Lambert, J. J., and Peters, J. A. (1999) Mol. Pharmacol. 55, 1037-1043
51. Gurley, D. A., and Lanthorn, T. H. (1998) Neurosci. Lett. 247, 107-110
52. Machu, T. K., Hamilton, M. E., Frye, T. F., Shanklin, C. L., Harris, M. C., Sun, H., Tenner, T. E., Soti, F. S., and Kem, W. R. (2001) J. Pharmacol. Exp. Ther. 299, 1112-1119
53. Eertmoed, A., Vajello, Y. F., and Green, W. N. (1999) Methods Enzymol. 293, 564-585
54. Drisdel, R. C., and Green, W. N. (2000) J. Neurosci. 20, 133-139
55. Gnadisch, D., London, E. D., Terry, P., Hill, G. R., and Mukhin, A. G. (1999) Neuroreport 10, 1631-1636
56. Adodra, S., and Hales, T. G. (1995) Br. J. Pharmacol. 115, 953-960
57. Davila-Garcia, M. I., Musachio, J. L., and Kellar, K. J. (2003) J. Neurochem. 85, 1237-1246
58. Reeves, D. C., and Lummis, C. R. (2006) BMC Neurosci. 7, doi:10.1186/1471-2202-7-27
59. Oortgiesen, M., van Kleef, R. G., and Vijverberg, H. P. (1997) Brain Res. 747, 1-8
60. Stewart, A., Davies, P. A., Kirkness, E. F., Safa, P., and Hales, T. G. (2003) Neuropharmacology 44, 214-223
61. Lambert, J. J., Peters, J. A., Hales, T. G., and Dempster, J. (1989) Br. J. Pharmacol. 97, 27-40
62. Parker, S. L., Fu, Y., McAllen, K., Luo, J., McIntosh, J. M., Lindstrom, J. M., and Sharp, B. M. (2004) Mol. Pharmacol. 65, 611-622
63. Whiteaker, P., Jimenez, M., McIntosh, J. M., Collins, A. C., and Marks, M. J. (2000) Br. J. Pharmacol. 131, 729-739
64. McCallum, S. E., Collins, A. C., Paylor, R., and Marks, M. J. (2006) Psychopharmacology 184, 314-327
65. Marks, M. J., Whiteaker, P., and Collins, A. C. (2006) Mol. Pharmacol. 70, 947-959
66. Macor, J. E., Gurley, D. A., Lanthorn, T. H., Loch, J., Mack, R. A., Mullen, G., Tran, O., Wright, N., and Gordon, C. (2001) Bioorg. Med. Chem. Lett. 44, 319-321
67. Broad, L. M., Felthouse, C., Zwart, R., McPhie, G. I., Pearson, K. H., Craig, P. J., Wallace, L., Broadmore, R. J., Boot, J. R., Keenan, M., Baker, S. R., and Sher, E. (2002) Eur. J. Pharmacol. 452, 137-144
68. Curzon, P., Nikkel, A. L., Bannon, A. W., Arneric, S. P., and Decker, M. W. (1998) J. Pharmacol. Exp. Ther. 287, 847-853
69. Rashid, M. H., and Ueda, H. (2002) Brain Res. 953, 53-62
70. Sullivan, J. P., Decker, M. W., Brioni, J. D., Donnelly-Roberts, D. L., Anderson, D. J., Bannon, A. W., Kang, C., Adams, P., Piattoni-Kaplan, M., Buckley, M. J., Gopalakrishnan, M., Williams, M., and Arneric, S. P. (1994) J. Pharmacol. Exp. Ther. 271, 624-631
71. Sacaan, A. I., Menzaghi, F., Dunlop, J. L., Correa, L. D., Whelan, K. T., and Lloyd, G. K. (1996) J. Pharmacol. Exp. Ther. 276, 509-515
72. Alkondon, M., and Albuquerque, E. X. (1996) J. Pharmacol. Exp. Ther. 274, 771-782
73. Lecchi, M., McIntosh, J. M., Bertrand, S., Safran, A. B., and Bertrand, D. (2005) J. Neurosci. 21, 3182-3188
74. Buisson, B., Vallejo, Y. F., Green, W. N., and Bertrand, D. (2000) Neuropharmacology 39, 2561-2569